News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Market source Earnings
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Mercury General (MCY) is back on investors' radar after Mercury Insurance introduced an enhanced homeowners product in Oklahoma, adding new hail, wind and wildfire related discounts and …
Leeward Financial Partners LLC has acquired a new position of 6,763 shares in Cummins Inc. (NYSE:CMI) valued at approximately $4.82 million, making it their 23rd largest holding. Institutional investors collectively own 83.46% of Cummins stock, and Wall Street analysts have a "Moderate Buy" rating …
Focus Partners Advisor Solutions LLC has acquired a new stake in Cummins Inc., purchasing 5,201 shares valued at approximately $3.71 million during the second quarter. Other institutional investors like Northwestern Mutual Wealth Management Co. and Norges Bank also significantly increased their holdings in Cummins. …
ICU Medical, Inc. (NASDAQ:ICUI) has received a "Moderate Buy" consensus rating from nine analysts, with an average 12-month price target of $192.80. The company recently surpassed quarterly earnings and revenue expectations, reporting $2.37 EPS on $547.88 million in revenue, and provided fiscal 2026 EPS …
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Curtiss-Wright stock has delivered a very large 5 year return, yet current valuation checks suggest the shares now trade at a premium to an intrinsic value estimate …
ABN AMRO Bank N.V. recently acquired 46,273 shares of Cummins Inc. (NYSE:CMI) valued at approximately $32.11 million during the second quarter. This purchase makes ABN AMRO Bank N.V. a new significant institutional investor in Cummins, joining several other firms that have also adjusted their …
This article provides a comprehensive list of Exchange Traded Funds (ETFs) that hold Mercury Systems, Inc. (MRCY) stocks. The list is sorted by market value and includes various details for each ETF, such as issuer, management style, expense ratio, assets under management (AUM), and …
Bellars Harris Wealth Management LLC recently acquired 13,609 shares of Cummins Inc. (NYSE:CMI), valued at approximately $9.71 million, making it their 13th largest holding. Other institutional investors also adjusted their positions in Cummins, which reported quarterly earnings of $6.73 per share, missing consensus estimates, …
NAPCO Security Technologies (NASDAQ: NSSC) has received an average rating of "Moderate Buy" from eight analysts, with six recommending a buy and two a hold. The average 12-month price target is $48.67, indicating potential upside from its current $38.32. Recent analyst actions include TD …
Jabil, Inc. (NYSE:JBL) has received a consensus "Buy" rating from ten brokerages, with an average 12-month price target of $453.67. The company recently surpassed quarterly expectations with $3.16 EPS and $8.75 billion in revenue, an 11.8% year-over-year increase. Institutional investors hold 93.39% of Jabil's …
Wall Street Zen has upgraded Atlanticus (NASDAQ:ATLC) stock rating from "buy" to "strong-buy," aligning with a broader "Moderate Buy" consensus from analysts with an average price target of $126. This upgrade follows Atlanticus exceeding its quarterly earnings expectations, reporting $2.50 EPS on $744.31 million …
Ocugen is aiming for 2027 Biologics License Application (BLA) filings for its OCU400 retinitis pigmentosa and OCU410ST Stargardt disease gene therapies, with potential launches in 2028. The company expects key clinical readouts next year, including Phase III OCU400 data in Q1 and Phase II/III …
Celcuity Inc. (CELC) reported a wider Q2 net loss of US$78.86 million but secured FDA approval and NCCN Category 1 status for Revtopik, its breast cancer drug. This development significantly alters the company's investment narrative, shifting focus from gedatolisib's potential to Revtopik's commercialization and …
On August 6, Curtiss-Wright (NYSE:CW) held its second quarter 2026 earnings call and reported that the company's sales climbed 5% year-over-year to $924 million, but the real story was underneath. Operating income grew 12%, more than double the pace of revenue, pushing margins up …
Curtiss-Wright (CW) recently reported strong Q2 2026 earnings, surpassing expectations and raising full-year guidance, which has positively impacted its stock price. The company's fair value is estimated to be around $814.83 per share, indicating it is currently undervalued despite its strong P/E ratio. Investors …
Alexander Otto, a director at Curbline Properties Corp. (NYSE:CURB), sold a total of 231,943 common shares over two trading days, August 12 and 13, 2026. The sales were executed via his affiliated entity, KG Cura Vermogensverwaltung G.m.b.H. & Co., at weighted average prices of …
Maxim Group has reiterated its Buy rating for Moleculin Biotech (MBRX.US) but has reduced the target price for the stock to $2. This adjustment reflects a revised outlook on the company's valuation while maintaining a positive long-term perspective.
Search by ticker symbol or company name and select a result to open its chart.